Short Interest in IGC Pharma, Inc. (NYSEAMERICAN:IGC) Decreases By 16.3%

IGC Pharma, Inc. (NYSEAMERICAN:IGC) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totaling 315,961 shares, a drop of 16.3% from the December 31st total of 377,332 shares. Based on an average daily volume of 424,506 shares, the short-interest ratio is presently 0.7 days. Currently, 0.4% of the company’s shares are sold short. Currently, 0.4% of the company’s shares are sold short. Based on an average daily volume of 424,506 shares, the short-interest ratio is presently 0.7 days.

IGC Pharma Stock Down 4.4%

Shares of NYSEAMERICAN:IGC traded down $0.01 during trading on Wednesday, reaching $0.26. The stock had a trading volume of 433,658 shares, compared to its average volume of 438,174. The company has a current ratio of 1.32, a quick ratio of 0.89 and a debt-to-equity ratio of 0.02. The firm has a market cap of $24.52 million, a PE ratio of -3.69 and a beta of 0.33. The firm’s fifty day moving average is $0.30. IGC Pharma has a fifty-two week low of $0.25 and a fifty-two week high of $0.50.

IGC Pharma (NYSEAMERICAN:IGC) last announced its earnings results on Friday, November 14th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm had revenue of $0.19 million for the quarter. IGC Pharma had a negative return on equity of 96.54% and a negative net margin of 583.91%.

About IGC Pharma

IGC Pharma, Inc, a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer’s disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer’s disease comprising IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer’s; and TGR-63 that is in pre-clinical development. It also markets Holief, a wellness brand that targets women experiencing premenstrual syndrome and menstrual cramps.